drugset / Trial / NCT00075413

Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer

NCT00075413

Treatment

Summary

RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well arsenic trioxide works in treating women with locally advanced or metastatic breast cancer.

Timeline

Start
2002-11
Primary completion
2005-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject arsenic trioxide Small molecule Intravenous

Indications